109 related articles for article (PubMed ID: 17804759)
1. Comment on: A validated mathematical model of cell-mediated immune response to tumor growth.
Gowal S; de Giacomi M; Le Boudec JY
Cancer Res; 2007 Sep; 67(17):8419-21; author reply 8420-1. PubMed ID: 17804759
[No Abstract] [Full Text] [Related]
2. A validated mathematical model of cell-mediated immune response to tumor growth.
de Pillis LG; Radunskaya AE; Wiseman CL
Cancer Res; 2005 Sep; 65(17):7950-8. PubMed ID: 16140967
[TBL] [Abstract][Full Text] [Related]
3. A cellular automata model of tumor-immune system interactions.
Mallet DG; De Pillis LG
J Theor Biol; 2006 Apr; 239(3):334-50. PubMed ID: 16169016
[TBL] [Abstract][Full Text] [Related]
4. Differing phenotypes between intraepithelial and stromal lymphocytes in early-stage tongue cancer.
Katou F; Ohtani H; Watanabe Y; Nakayama T; Yoshie O; Hashimoto K
Cancer Res; 2007 Dec; 67(23):11195-201. PubMed ID: 18056444
[TBL] [Abstract][Full Text] [Related]
5. Comment on "Critical roles of NK and CD8+ T cells in central nervous system listeriosis".
Deckert M; Schlüter D
J Immunol; 2009 Nov; 183(9):5437; author reply 5437-8. PubMed ID: 19843929
[No Abstract] [Full Text] [Related]
6. Endogenous IL-21 restricts CD8+ T cell expansion and is not required for tumor immunity.
Søndergaard H; Coquet JM; Uldrich AP; McLaughlin N; Godfrey DI; Sivakumar PV; Skak K; Smyth MJ
J Immunol; 2009 Dec; 183(11):7326-36. PubMed ID: 19915059
[TBL] [Abstract][Full Text] [Related]
7. Synergistic effect of intratumoral IL-12 and TNF-alpha microspheres: systemic anti-tumor immunity is mediated by both CD8+ CTL and NK cells.
Sabel MS; Arora A; Su G; Mathiowitz E; Reineke JJ; Chang AE
Surgery; 2007 Nov; 142(5):749-60. PubMed ID: 17981196
[TBL] [Abstract][Full Text] [Related]
8. Model-free feedback design for a mixed cancer therapy.
Chareyron S; Alamir M
Biotechnol Prog; 2009; 25(3):690-700. PubMed ID: 19301260
[TBL] [Abstract][Full Text] [Related]
9. Multiple roles for CD4+ T cells in anti-tumor immune responses.
Kennedy R; Celis E
Immunol Rev; 2008 Apr; 222():129-44. PubMed ID: 18363998
[TBL] [Abstract][Full Text] [Related]
10. Cytokine-induced killer cells are terminally differentiated activated CD8 cytotoxic T-EMRA lymphocytes.
Franceschetti M; Pievani A; Borleri G; Vago L; Fleischhauer K; Golay J; Introna M
Exp Hematol; 2009 May; 37(5):616-628.e2. PubMed ID: 19375652
[TBL] [Abstract][Full Text] [Related]
11. Distinct human circulating NKp30
Correia MP; Stojanovic A; Bauer K; Juraeva D; Tykocinski LO; Lorenz HM; Brors B; Cerwenka A
Proc Natl Acad Sci U S A; 2018 Jun; 115(26):E5980-E5989. PubMed ID: 29895693
[TBL] [Abstract][Full Text] [Related]
12. Cathepsin W expressed exclusively in CD8+ T cells and NK cells, is secreted during target cell killing but is not essential for cytotoxicity in human CTLs.
Stoeckle C; Gouttefangeas C; Hammer M; Weber E; Melms A; Tolosa E
Exp Hematol; 2009 Feb; 37(2):266-75. PubMed ID: 19100676
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of T cell and natural killer cell function by adenosine and its contribution to immune evasion by tumor cells (Review).
Hoskin DW; Mader JS; Furlong SJ; Conrad DM; Blay J
Int J Oncol; 2008 Mar; 32(3):527-35. PubMed ID: 18292929
[TBL] [Abstract][Full Text] [Related]
14. Do we have memory of danger as well as antigen?
Noble A
Trends Immunol; 2009 Apr; 30(4):150-6. PubMed ID: 19286426
[TBL] [Abstract][Full Text] [Related]
15. The dual effects of interleukin-18 in tumor progression.
Park S; Cheon S; Cho D
Cell Mol Immunol; 2007 Oct; 4(5):329-35. PubMed ID: 17976312
[TBL] [Abstract][Full Text] [Related]
16. CD8+ regulatory T cells, their suppressive mechanisms, and regulation in cancer.
Wang RF
Hum Immunol; 2008 Nov; 69(11):811-4. PubMed ID: 18817828
[TBL] [Abstract][Full Text] [Related]
17. A simple, economic, time-resolved killing assay.
Kummerow C; Schwarz EC; Bufe B; Zufall F; Hoth M; Qu B
Eur J Immunol; 2014 Jun; 44(6):1870-2. PubMed ID: 24599783
[No Abstract] [Full Text] [Related]
18. Antigen-nonspecific activation of CD8+ T lymphocytes by cytokines: relevance to immunity, autoimmunity, and cancer.
Ramanathan S; Gagnon J; Ilangumaran S
Arch Immunol Ther Exp (Warsz); 2008; 56(5):311-23. PubMed ID: 18836862
[TBL] [Abstract][Full Text] [Related]
19. Modelling the influence of activation-induced apoptosis of CD4+ and CD8+ T-cells on the immune system response of a HIV-infected patient.
Stan GB; Belmudes F; Fonteneau R; Zeggwagh F; Lefebvre MA; Michelet C; Ernst D
IET Syst Biol; 2008 Mar; 2(2):94-102. PubMed ID: 18397120
[TBL] [Abstract][Full Text] [Related]
20. Early kinetics of innate and adaptive immune responses during hepatitis B virus infection.
Fisicaro P; Valdatta C; Boni C; Massari M; Mori C; Zerbini A; Orlandini A; Sacchelli L; Missale G; Ferrari C
Gut; 2009 Jul; 58(7):974-82. PubMed ID: 19201769
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
